Published in Health Business Week, April 13th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Dendrite International.
Report 1: CEGEDIM S.A. (Euronext: CGM) and Dendrite International, Inc. (NASDAQ: DRTE) announced a definitive merger agreement under which CEGEDIM will acquire Dendrite for $16.00 per outstanding share in cash.
Per the terms of the agreement, Dendrite is valued on a fully diluted equity basis at approximately $751 million, which represents a premium of approximately 40% over the average closing share price for Dendrite...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.